ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01377922
Brief Title: A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

First Submitted : June 17, 2011
First Submitted that Met QC Criteria : June 20, 2011
First Posted : June 22, 2011 (Estimate)

Results First Submitted : September 28, 2017
Results First Submitted that Met QC Criteria : January 3, 2018
Results First Posted : January 4, 2018

Last Update Submitted that Met QC Criteria : January 3, 2018
Last Update Posted : January 4, 2018